Alpex Acquisition Corporation (NASDAQ:ALPX – Get Free Report) was the target of a large growth in short interest during the month of October. As of October 15th, there was short interest totaling 80,484 shares, a growth of 62,290.7% from the September 30th total of 129 shares. Based on an average trading volume of 38,303 shares, the days-to-cover ratio is presently 2.1 days.
Alpex Acquisition Stock Up 0.2%
Shares of ALPX stock traded up $0.02 during trading hours on Monday, hitting $9.99. 511,254 shares of the company were exchanged, compared to its average volume of 98,684. The company has a 50 day moving average of $9.95. Alpex Acquisition has a 52 week low of $9.81 and a 52 week high of $10.00.
Analyst Ratings Changes
ALPX has been the subject of several recent analyst reports. Weiss Ratings started coverage on shares of Alpex Acquisition in a research note on Tuesday, September 29th. They issued a “sell (e)” rating for the company. Wall Street Zen upgraded shares of Alpex Acquisition to a “hold” rating in a report on Saturday, August 1st. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Alpex Acquisition presently has a consensus rating of “Sell”.
View Our Latest Analysis on ALPX
About Alpex Acquisition
Alpex Acquisition Corp. (NASDAQ: ALPX) is a special purpose acquisition company, or SPAC, formed to identify and complete a business combination with an operating company. Potential transactions may include a merger, share exchange, asset acquisition, or similar corporate combination.
Unlike an operating company, Alpex Acquisition does not have established products, services, or commercial operations of its own. Its activities are primarily focused on evaluating potential acquisition targets, negotiating a transaction, and securing shareholder approval for any proposed business combination.
The company was incorporated in the Cayman Islands and was established as a publicly traded acquisition vehicle.
Featured Articles
- Five stocks we like better than Alpex Acquisition
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Alpex Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpex Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
